Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

COT - Centro Oncologico do Triangulo Ltda.

     
Santa Minica Uberlandia ,
Brazil

 

Principal Investigator:
 Valeria R. Lopes, MD Val.
Contact:
 Priscilla C. Azvedo Estrada (34) 3291-3500 (34) 9118-9638 priscilla@cot-onco.com.br
Activation Status of this Site:
 Closed
Notes about this Site:
COT - Centro Oncologico do Triangulo Ltda. Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.